Atreca, Inc. Banner Image

Atreca, Inc.

  • Ticker BCEL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Atreca, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Atreca is a biopharmaceutical company developing novel antibody-based immunotherapeutics generated by its differentiated discovery platform. Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basisMore for first-in-class therapeutic candidates, such as their lead product candidate ATRC-101. A Phase 1b study evaluating ATRC-101 in multiple solid tumor cancers is currently enrolling patients.
4.8 / 5.0 (140)

Atreca, Inc. reports have an aggregate usefulness score of 4.8 based on 140 reviews.

Atreca, Inc.

Most Recent Annual Report

Atreca, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Atreca, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!